Skip to main content
  • Saved

made a Post

FDA Approves First Liquid Biopsy Next-Generation Sequencing Companion Diagnostic Test

FDA Approves First Liquid Biopsy Next-Generation Sequencing Companion Diagnostic Test

Source :

https://www.fda.gov/news-events/press-announcements/fda-approves-first-liquid-biopsy-next-generation-sequencing-companion-diagnostic-test

Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).